Novel “Jantibody Fusion Protein” Cancer Vaccine Holds Promise Against Ovarian Cancer

A novel approach to cancer immunotherapy – strategies designed to induce the immune system to attack cancer cells – may provide a new and cost-effective weapon against some of the most deadly tumors, including ovarian cancer and mesothelioma. A novel approach to cancer immunotherapy – strategies designed to induce the immune system to attack cancer […]
Source: Libby's H*O*P*E* - Category: Cancer Authors: Tags: Discoveries Immunotherapy Preclinical Testing Vaccines cancer vaccine dendritic cell Harvard Medical School Jantibody fusion protein Jeff Gelfand M.D. Mark Poznansky M.D. Ph.D. Massachusetts General Hospital mesothelin MGH Vaccine Source Type: blogs